Fairvalue-Calculator Fairvalue-Calculator
EN DE

Mercuries Life Insurance Company (2867) Fair Value & Analysis

Financial Services · TW · Market cap 48.6B TWD

Price8.51 TWD
Fair Value2.60 TWD
Upside-69.4%
Quality95/100
Evidence: High Range 1.95 TWD – 3.25 TWD

Analysis

Mercuries Life Insurance Company (2867) currently trades at 8.51 TWD, while our model-based Fair Value estimate is 2.60 TWD — implying the stock looks roughly 69.4% overvalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Mercuries Life Insurance Company Ltd. provides life insurance products in Taiwan. The company offers health, life, accident, annuities, group, universal, and investment insurance products. It also provides term life, whole life, and pension insurance; immediate and deferred annuity; health, hospitalization, cancer or critical illness, and long-term care and disability insurance, and premium waiver/other; injury, accident, and travel insurance; investment; group; and others insurances. Mercuries Life Insurance Company Ltd. was incorporated in 1993 and is based in Taipei, Taiwan.

Open the full interactive analysis →

Similar stocks

Ping An Insurance (Group) Company (601318) +100% China Life Insurance Company (601628) +100% AIA Group (AAGIY) +23% Manulife Financial Corporation (MFC) -16% China Pacific Insurance (Group) Co (CHPXF) +60% Aflac Incorporated (AFL) -33%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.